101
|
Forrest LF, Sowden S, Rubin G, White M, Adams J. Socio-economic inequalities in stage at diagnosis, and in time from first symptom to treatment, for lung cancer: systematic review and meta-analysis. Eur J Public Health 2014. [DOI: 10.1093/eurpub/cku151.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
102
|
Wright J, Kamp E, White M, Adams J, Sowden S. Food at checkouts in non-food stores: a cross-sectional study of a large indoor shopping mall in Gateshead UK, February - March 2014. Eur J Public Health 2014. [DOI: 10.1093/eurpub/cku166.127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
103
|
Desjardins A, Nigam A, Juneau M, Lapierre G, White M, Gremeaux V, Gayda M. CEREBRAL OXYGENATION/PERFUSION, CARDIOPULMONARY AND HEMODYNAMIC RESPONSES DURING MAXIMAL INCREMENTAL EXERCISE IN HEART TRANSPLANT RECIPIENTS VS. HEALTHY CONTROL SUBJECTS. Can J Cardiol 2014. [DOI: 10.1016/j.cjca.2014.07.549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
104
|
Orton L, Pennington A, Nayak S, Whitehead M, Petticrew M, White M, Sowden A. The health inequalities impact of low control in the living environment: a theory-led systematic review of observational studies. Eur J Public Health 2014. [DOI: 10.1093/eurpub/cku162.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
105
|
Chaar D, Vitiello D, Neagoe P, Ducharme A, Carrier M, Pelletier G, Racine N, Lizkowski M, Sirois M, White M. DECREASED CIRCULATING AND NEUTROPHIL MEDIATED VEGF RELEASE IN STABLE LONG-TERM CARDIAC TRANSPLANT RECIPIENTS. Can J Cardiol 2014. [DOI: 10.1016/j.cjca.2014.07.340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
106
|
Powell K, Green J, Milton S, Buckner S, White M, Moffatt S, Salway S. Older people’s wellbeing in the UK: what role do universal welfare benefits play? Eur J Public Health 2014. [DOI: 10.1093/eurpub/cku161.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
107
|
Forrest LF, Adams J, White M, Rubin G. Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study. Br J Cancer 2014; 111:1843-51. [PMID: 25203519 PMCID: PMC4453730 DOI: 10.1038/bjc.2014.472] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2014] [Revised: 07/14/2014] [Accepted: 07/24/2014] [Indexed: 11/26/2022] Open
Abstract
Background: The NHS Cancer Plan for England set waiting time targets for cancer referral (14 days from GP referral to first hospital appointment) and treatment (31 days from diagnosis, 62 days from urgent GP referral). Interim diagnostic intervals can also be calculated. The factors that influence timely post-primary care referral, diagnosis and treatment for lung cancer are not known. Methods: Northern and Yorkshire Cancer Registry, Hospital Episode Statistics and lung cancer audit data sets were linked. Logistic regression was used to investigate the factors (socioeconomic position, age, sex, histology, co-morbidity, year of diagnosis, stage and performance status (PS)) that may influence the likelihood of referral, diagnosis and treatment within target, for 28 733 lung cancer patients diagnosed in 2006–2010. Results: Late-stage, poor PS and small-cell histology were associated with a higher likelihood of post-primary care referral, diagnosis and treatment within target. Older patients were significantly less likely to receive treatment within the 31-day (odds ratio (OR)=0.79, 95% confidence interval (CI) 0.69–0.91) and 62-day target (OR=0.80, 95% CI 0.67–0.95) compared with younger patients. Conclusions: Older patients waited longer for treatment and this may be unjustified. Patients who appeared ill were referred, diagnosed and treated more quickly and this ‘sicker quicker' effect may cancel out system socioeconomic inequalities that might result in longer time intervals for more deprived patients.
Collapse
|
108
|
Forrest LF, White M, Rubin G, Adams J. OP27 Factors associated with timely referral, diagnosis and treatment for lung cancer: cohort study using linked cancer registry, Hospital Episode Statistics, and audit data. Br J Soc Med 2014. [DOI: 10.1136/jech-2014-204726.30] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
109
|
Forrest LF, White M, Rubin G, Adams J. PP59 Intervention-generated inequalities in lung cancer care: cohort study using linked cancer registry, Hospital Episode Statistics, and audit data. Br J Soc Med 2014. [DOI: 10.1136/jech-2014-204726.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
110
|
Alamgeer M, White M, Stuckey J, Harris M, Kumar B, Hart S, Fox J, Watkins D, Ganju V. Prediction of Axillary Lymph Node Response to Neoadjuvant Chemotherapy (Nac) By Changes in Maximum Standard Uptake Values (Suvmax) with 18Fdg-Pet (Pet) Imaging of the Primary Breast Tumour. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu328.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
111
|
Orton LC, Pennington A, Nayak S, Whitehead M, Petticrew M, White M, Sowden A. PP43 Do microfinance initiatives improve women’s health? A systematic review of women’s empowerment interventions. Br J Soc Med 2014. [DOI: 10.1136/jech-2014-204726.138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
112
|
Fleming LE, McDonough N, Austen M, Mee L, Moore M, Hess P, Depledge MH, White M, Philippart K, Bradbrook P, Smalley A. Oceans and Human Health: a rising tide of challenges and opportunities for Europe. MARINE ENVIRONMENTAL RESEARCH 2014; 99:16-9. [PMID: 25081849 DOI: 10.1016/j.marenvres.2014.05.010] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/19/2014] [Accepted: 05/25/2014] [Indexed: 05/06/2023]
Abstract
The European Marine Board recently published a position paper on linking oceans and human health as a strategic research priority for Europe. With this position paper as a reference, the March 2014 Cornwall Oceans and Human Health Workshop brought together key scientists, policy makers, funders, business, and non governmental organisations from Europe and the US to review the recent interdisciplinary and cutting edge research in oceans and human health specifically the growing evidence of the impacts of oceans and seas on human health and wellbeing (and the effects of humans on the oceans). These impacts are a complex mixture of negative influences (e.g. from climate change and extreme weather to harmful algal blooms and chemical pollution) and beneficial factors (e.g. from natural products including seafood to marine renewable energy and wellbeing from interactions with coastal environments). Integrated approaches across disciplines, institutions, and nations in science and policy are needed to protect both the oceans and human health and wellbeing now and in the future.
Collapse
|
113
|
Forrest LF, White M, Rubin G, Adams J. The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study. Br J Cancer 2014; 111:608-18. [PMID: 24918815 PMCID: PMC4119983 DOI: 10.1038/bjc.2014.310] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2014] [Revised: 05/09/2014] [Accepted: 05/12/2014] [Indexed: 11/18/2022] Open
Abstract
Background: Reducing socioeconomic inequalities in lung cancer treatment may reduce survival inequalities. However, the reasons for treatment variation are unclear. Methods: Northern and Yorkshire cancer registry, Hospital Episode Statistics and lung cancer audit data sets were linked. Logistic regression was used to explore the role of stage, histology, performance status and comorbidity in socioeconomic inequalities in lung cancer treatment, for 28 733 lung cancer patients diagnosed in 2006–2010, and in a subgroup with stage recorded (n=7769, 27%). Results: Likelihood of receiving surgery was significantly lower in the most deprived group (odds ratio (OR)=0.75, 95% confidence interval (CI) 0.65–0.86); however, the OR was attenuated when including histological subtype (OR=0.82, 95% CI 0.71–0.96). Patients in the most deprived group were significantly less likely to receive chemotherapy in the fully adjusted full cohort model including performance status (OR=0.64, 95% CI 0.58–0.72) but not in the staged subgroup model when performance status was included (OR=0.88, 95% CI 0.72–1.08). Socioeconomic inequalities in radiotherapy were not found. Interpretation: Socioeconomic inequalities in performance status statistically explained socioeconomic inequalities in receipt of chemotherapy in the selective staged subgroup, but not in the full cohort. Socioeconomic variation in histological subtype may account for some of the socioeconomic inequalities in surgery.
Collapse
|
114
|
Nair M, Li C, White M, Davis J. SU-E-T-634: Analysis of Volume Based GYN HDR Brachytherapy Plans for Dose Calculation to Organs At Risk(OAR). Med Phys 2014. [DOI: 10.1118/1.4888970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
115
|
Zhang J, Syh J, Syh J, White M, Patel B, Song X, Wu H. SU-E-T-200: IBA ProteusOne Compact Proton Therapy System Radiation Survey Results. Med Phys 2014. [DOI: 10.1118/1.4888530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
116
|
Glen JB, White M. A comparison of the predictive performance of three pharmacokinetic models for propofol using measured values obtained during target-controlled infusion. Anaesthesia 2014; 69:550-7. [DOI: 10.1111/anae.12631] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/25/2014] [Indexed: 11/24/2022]
|
117
|
Hollander Z, Lam K, Wilson-McManus J, Assadian S, Dai D, Shannon C, Chen V, Tebbutt S, Balshaw R, Borchers C, Davies R, Delgado D, Haddad H, Ignaszewski A, Isaac D, Kim D, Mui A, Rajda M, Ross H, West L, White M, Zieroth S, McMaster R, Keown P, Ng R, McManus B. Blood Test to Monitor for the Absence of Acute Cardiac Rejection: From Discovery to Clinical Implementation. J Heart Lung Transplant 2014. [DOI: 10.1016/j.healun.2014.01.099] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
118
|
Toma M, Hollander Z, Wilson-McManus J, Lin D, Lam K, Dai D, Cohen Freue G, Tebbutt S, Balshaw R, Borchers C, Davies R, Delgado D, Haddad H, Ignaszewski A, Isaac D, Kim D, Rajda M, Ross H, West L, White M, Zieroth S, Mancini J, McMaster R, Keown P, Ng R, McManus B. Plasma Protein Biosignatures for Detection of Cardiac Allograft Vasculopathy. J Heart Lung Transplant 2014. [DOI: 10.1016/j.healun.2014.01.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
119
|
Santhi C, Kannan N, White M, Di Luzio M, Arnold JG, Wang X, Williams JR. An integrated modeling approach for estimating the water quality benefits of conservation practices at the river basin scale. JOURNAL OF ENVIRONMENTAL QUALITY 2014; 43:177-198. [PMID: 25602551 DOI: 10.2134/jeq2011.0460] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The USDA initiated the Conservation Effects Assessment Project (CEAP) to quantify the environmental benefits of conservation practices at regional and national scales. For this assessment, a sampling and modeling approach is used. This paper provides a technical overview of the modeling approach used in CEAP cropland assessment to estimate the off-site water quality benefits of conservation practices using the Ohio River Basin (ORB) as an example. The modeling approach uses a farm-scale model, Agricultural Policy Environmental Extender (APEX), and a watershed scale model (the Soil and Water Assessment Tool [SWAT]) and databases in the Hydrologic Unit Modeling for the United States system. Databases of land use, soils, land use management, topography, weather, point sources, and atmospheric depositions were developed to derive model inputs. APEX simulates the cultivated cropland, Conserve Reserve Program land, and the practices implemented on them, whereas SWAT simulates the noncultivated land (e.g., pasture, range, urban, and forest) and point sources. Simulation results from APEX are input into SWAT. SWAT routes all sources, including APEX's, to the basin outlet through each eight-digit watershed. Each basin is calibrated for stream flow, sediment, and nutrient loads at multiple gaging sites and turned in for simulating the effects of conservation practice scenarios on water quality. Results indicate that sediment, nitrogen, and phosphorus loads delivered to the Mississippi River from ORB could be reduced by 16, 15, and 23%, respectively, due to current conservation practices. Modeling tools are useful to provide science-based information for assessing existing conservation programs, developing future programs, and developing insights on load reductions necessary for hypoxia in the Gulf of Mexico.
Collapse
|
120
|
White M, Foulis AK, Smith G, Horgan PG, Roxburgh CS. The role of S100 staining in the pathological assessment of perineural invasion in rectal cancer. Colorectal Dis 2014; 16:71-2. [PMID: 24164952 DOI: 10.1111/codi.12471] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/29/2013] [Accepted: 09/20/2013] [Indexed: 02/08/2023]
|
121
|
Isaacs C, Ozguroglu M, Jerusalem G, Xu B, Láng I, O'Regan R, White M, Fasolo A, Litton J, Toi M, Shen K, Andre F, Vuylsteke P, Zhang Y, Zhang J, Taran T, Wilks S. Abstract P4-12-18: BOLERO-3: Quality-of-life maintained in patients with metastatic breast cancer treated with everolimus plus trastuzumab plus vinorelbine. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p4-12-18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Activation of the PI3K/mTOR pathway is implicated in resistance to trastuzumab. Accordingly, the BOLERO-3 study evaluated the efficacy of adding everolimus (EVE), an mTOR inhibitor, to vinorelbine and trastuzumab. At the final progression-free survival (PFS) analysis, EVE significantly improved PFS vs PBO (hazard ratio [HR] = 0.78; log-rank P = .0067) but EVE-treated patients had higher rate of grade 3/4 toxicity. To further qualify the benefit:risk of adding EVE to trastuzumab-based therapy, per-protocol, patient-reported, health-related quality-of-life (HRQoL) data were analyzed.
Methods: BOLERO-3 is a randomized phase 3, double-blind, placebo-controlled, international multicenter trial. Taxane-pretreated patients (N = 569) with trastuzumab-resistant, HER2+, advanced breast cancer were randomized (1:1) to treatment with EVE or placebo (PBO) plus vinorelbine and trastuzumab. The European Organisation for Research and Treatment of Cancer (EORTC) quality-of-life questionnaire C30 (QLQ-C30) (including the breast cancer-specific BR23 module) was administered at baseline and every 6 weeks thereafter until progression. The QLQ-C30 consists of 30 items combined into 15 subscales, including Global Health Status and functional subscales, where higher scores (range, 0 to 100) indicate better HRQoL. Time to definitive deterioration (TTD) based on a 10% decrease from baseline for GHS and for the physical, emotional, and social function subscales was determined using the Kaplan-Meier method. Treatment arms were compared using a 2-sided log-rank test stratified by prior use of lapatinib.
Results: Overall, there was no significant difference in median TDD of HRQoL between treatment arms. The median TTD in global health status score was 8.3 months for EVE (95% confidence interval [CI], 6.9-11.5) vs 7.3 months for PBO (95% CI, 5.6-10.4; P = .8386). The median TTD in the physical, emotional, and social function subscale scores showed no significant difference between arms. For example, median TTD in the physical function subscale score was 12.0 months (95% CI, 8.3-14.1) for EVE vs 12.5 months (95% CI, 8.3-20.9) for PBO (P = .4251), and median TTD in the emotional function subscale score was 15.2 months (95% CI, 9.2-17.3) for EVE vs 12.5 months (95% CI, 9.7-16.4) for PBO (P = .8140).
Conclusions: These analyses demonstrate that, despite increased frequency of adverse events observed with the addition of EVE to the standard treatment of vinorelbine and trastuzumab, overall and functional HRQoL scores were not negatively impacted in patients with trastuzumab-resistant, HER2+, advanced breast cancer.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P4-12-18.
Collapse
|
122
|
Reis S, Morris G, Fleming LE, Beck S, Taylor T, White M, Depledge MH, Steinle S, Sabel CE, Cowie H, Hurley F, Dick JM, Smith RI, Austen M. Integrating health and environmental impact analysis. Public Health 2013; 129:1383-9. [PMID: 24099716 DOI: 10.1016/j.puhe.2013.07.006] [Citation(s) in RCA: 68] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2013] [Revised: 07/09/2013] [Accepted: 07/11/2013] [Indexed: 11/26/2022]
Abstract
Scientific investigations have progressively refined our understanding of the influence of the environment on human health, and the many adverse impacts that human activities exert on the environment, from the local to the planetary level. Nonetheless, throughout the modern public health era, health has been pursued as though our lives and lifestyles are disconnected from ecosystems and their component organisms. The inadequacy of the societal and public health response to obesity, health inequities, and especially global environmental and climate change now calls for an ecological approach which addresses human activity in all its social, economic and cultural complexity. The new approach must be integral to, and interactive, with the natural environment. We see the continuing failure to truly integrate human health and environmental impact analysis as deeply damaging, and we propose a new conceptual model, the ecosystems-enriched Drivers, Pressures, State, Exposure, Effects, Actions or 'eDPSEEA' model, to address this shortcoming. The model recognizes convergence between the concept of ecosystems services which provides a human health and well-being slant to the value of ecosystems while equally emphasizing the health of the environment, and the growing calls for 'ecological public health' as a response to global environmental concerns now suffusing the discourse in public health. More revolution than evolution, ecological public health will demand new perspectives regarding the interconnections among society, the economy, the environment and our health and well-being. Success must be built on collaborations between the disparate scientific communities of the environmental sciences and public health as well as interactions with social scientists, economists and the legal profession. It will require outreach to political and other stakeholders including a currently largely disengaged general public. The need for an effective and robust science-policy interface has never been more pressing. Conceptual models can facilitate this by providing theoretical frameworks and supporting stakeholder engagement process simplifications for inherently complex situations involving environment and human health and well-being. They can be tools to think with, to engage, to communicate and to help navigate in a sea of complexity. We believe models such as eDPSEEA can help frame many of the issues which have become the challenges of the new public health era and can provide the essential platforms necessary for progress.
Collapse
|
123
|
Pennington A, Orton L, Whitehead M, Ring A, Fox D, Petticrew M, White M, Sowden A. Missing women? The health inequalities impact of low control and gender discrimination: a theory-led systematic review of observational studies. Eur J Public Health 2013. [DOI: 10.1093/eurpub/ckt126.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
124
|
Vitiello D, Neagoe P, Sirois M, White M. Beneficial Effect of Mtor Inhibitors on Inflammation in Human Neutrophils. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
125
|
Tremblay-Gravel M, Khairy P, Roy D, Leduc H, Wyse D, Cadrin-Tourigny J, Macle L, Dubuc M, Andrade J, Rivard L, Guerra P, Thibault B, Talajic M, White M. Blood Pressure Levels Modulate Mortality in Patients With Atrial Fibrillation and Heart Failure With Depressed but not in Patients With Preserved Ejection Fraction. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|